Neurocysticercosis Prevalence and Characteristics in Communities of Sinda District in Zambia: A Cross-Sectional Study.
Taenia solium
Cysticercosis
Neurocysticercosis
Point-of-care test
Prevalence
Zambia
Journal
Journal of epidemiology and global health
ISSN: 2210-6014
Titre abrégé: J Epidemiol Glob Health
Pays: Switzerland
ID NLM: 101592084
Informations de publication
Date de publication:
09 Jul 2024
09 Jul 2024
Historique:
received:
19
04
2024
accepted:
24
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
9
7
2024
Statut:
aheadofprint
Résumé
This study aimed at describing the epidemiology of (neuro)cysticercosis as well as its clinical and radiological characteristics in a Taenia solium endemic district of Zambia. This was part of a cross-sectional community-based study conducted in Sinda district to evaluate an antibody-detecting T. solium point-of-care (TS POC) test for taeniosis and (neuro)cysticercosis. All TS POC cysticercosis positive (CC+) participants and a subset of the TS POC cysticercosis negative (CC-) received a clinical evaluation and cerebral computed tomography (CT) examination for neurocysticercosis (NCC) diagnosis and staging. Of the 1249 participants with a valid TS POC test result, 177 (14%) were TS POC CC+ . Cysticercosis sero-prevalence was estimated to be 20.1% (95% confidence intervals [CI] 14.6-27.0%). In total, 233 participants received a CT examination (151 TS POC CC+ , 82 TS POC CC-). Typical NCC lesions were present in 35/151 (23%) TS POC CC+ , and in 10/82 (12%) TS POC CC- participants. NCC prevalence was 13.5% (95% CI 8.4-21.1%) in the study population and 38.0% (95% CI 5.2-87.4%) among people reporting epileptic seizures. Participants with NCC were more likely to experience epileptic seizures (OR = 3.98, 95% CI 1.34-11.78, p = 0.01) than those without NCC, although only 7/45 (16%) people with NCC ever experienced epileptic seizures. The number of lesions did not differ by TS POC CC status (median: 3 [IQR 1-6] versus 2.5 [IQR 1-5.3], p = 0.64). Eight (23%) of the 35 TS POC CC+ participants with NCC had active stage lesions; in contrast none of the TS POC CC- participants was diagnosed with active NCC. NCC is common in communities in the Eastern province of Zambia, but a large proportion of people remain asymptomatic.
Sections du résumé
BACKGROUND
BACKGROUND
This study aimed at describing the epidemiology of (neuro)cysticercosis as well as its clinical and radiological characteristics in a Taenia solium endemic district of Zambia.
METHODS
METHODS
This was part of a cross-sectional community-based study conducted in Sinda district to evaluate an antibody-detecting T. solium point-of-care (TS POC) test for taeniosis and (neuro)cysticercosis. All TS POC cysticercosis positive (CC+) participants and a subset of the TS POC cysticercosis negative (CC-) received a clinical evaluation and cerebral computed tomography (CT) examination for neurocysticercosis (NCC) diagnosis and staging.
RESULTS
RESULTS
Of the 1249 participants with a valid TS POC test result, 177 (14%) were TS POC CC+ . Cysticercosis sero-prevalence was estimated to be 20.1% (95% confidence intervals [CI] 14.6-27.0%). In total, 233 participants received a CT examination (151 TS POC CC+ , 82 TS POC CC-). Typical NCC lesions were present in 35/151 (23%) TS POC CC+ , and in 10/82 (12%) TS POC CC- participants. NCC prevalence was 13.5% (95% CI 8.4-21.1%) in the study population and 38.0% (95% CI 5.2-87.4%) among people reporting epileptic seizures. Participants with NCC were more likely to experience epileptic seizures (OR = 3.98, 95% CI 1.34-11.78, p = 0.01) than those without NCC, although only 7/45 (16%) people with NCC ever experienced epileptic seizures. The number of lesions did not differ by TS POC CC status (median: 3 [IQR 1-6] versus 2.5 [IQR 1-5.3], p = 0.64). Eight (23%) of the 35 TS POC CC+ participants with NCC had active stage lesions; in contrast none of the TS POC CC- participants was diagnosed with active NCC.
CONCLUSION
CONCLUSIONS
NCC is common in communities in the Eastern province of Zambia, but a large proportion of people remain asymptomatic.
Identifiants
pubmed: 38980629
doi: 10.1007/s44197-024-00271-z
pii: 10.1007/s44197-024-00271-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European and Developing Countries Clinical Trials Partnership
ID : DRIA2014-308
Organisme : German Federal Ministry of Education and Research
ID : 01KA1617
Informations de copyright
© 2024. The Author(s).
Références
Flisser A. Where are the tapeworms? Parasitol Int. 2006. https://doi.org/10.1016/j.parint.2005.11.018 .
doi: 10.1016/j.parint.2005.11.018
pubmed: 16352463
Mwape KE, Phiri IK, Praet N, Speybroeck N, Muma JB, Dorny P, et al. The Incidence of Human Cysticercosis in a Rural Community of Eastern Zambia. PLoS Negl Trop Dis. 2013;7: e2142. https://doi.org/10.1371/journal.pntd.0002142 .
doi: 10.1371/journal.pntd.0002142
pubmed: 23556026
pmcid: 3605208
Winkler AS. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health. 2012;106:261–74. https://doi.org/10.1179/2047773212Y.0000000047 .
doi: 10.1179/2047773212Y.0000000047
pubmed: 23265550
pmcid: 4005109
Pradhan S, Kumar R, Gupta RK. Intermittent symptoms in neurocysticercosis: Could they be epileptic? Acta Neurol Scand. 2003;107:260–6. https://doi.org/10.1034/j.1600-0404.2003.01380.x .
doi: 10.1034/j.1600-0404.2003.01380.x
pubmed: 12675699
Stelzle D, Abraham A, Kaminski M, Schmidt V, De Meijere R, Bustos J, et al. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. J Travel Med. 2022. https://doi.org/10.1093/jtm/taac102 .
doi: 10.1093/jtm/taac102
Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4: e870. https://doi.org/10.1371/journal.pntd.0000870 .
doi: 10.1371/journal.pntd.0000870
pubmed: 21072231
pmcid: 2970544
Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5: e1152. https://doi.org/10.1371/journal.pntd.0001152 .
doi: 10.1371/journal.pntd.0001152
pubmed: 21629722
pmcid: 3101170
Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202–15. https://doi.org/10.1016/S1474-4422(14)70094-8 .
doi: 10.1016/S1474-4422(14)70094-8
pubmed: 25453460
pmcid: 6108081
Blocher J, Schmutzhard E, Wilkins PP, Gupton PN, Schaffert M, Auer H, et al. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis. 2011;5: e1185. https://doi.org/10.1371/journal.pntd.0001185 .
doi: 10.1371/journal.pntd.0001185
pubmed: 21666796
pmcid: 3110162
Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2011;9:123–33. https://doi.org/10.1586/eri.10.150 .
doi: 10.1586/eri.10.150
pubmed: 21171883
Gabriël S, Mwape KE, Phiri IK, Devleesschauwer B, Dorny P. Taenia solium control in Zambia: the potholed road to success. Parasite Epidemiol Control. 2019. https://doi.org/10.1016/j.parepi.2018.e00082 .
doi: 10.1016/j.parepi.2018.e00082
pubmed: 30662967
Zulu G, Stelzle D, Mwape KE, Welte TM, Strømme H, Mubanga C, et al. The epidemiology of human Taenia solium infections: A systematic review of the distribution in Eastern and Southern Africa. PLoS Negl Trop Dis. 2023;17: e0011042. https://doi.org/10.1371/JOURNAL.PNTD.0011042 .
doi: 10.1371/JOURNAL.PNTD.0011042
pubmed: 37000841
pmcid: 10096517
Phiri IK, Dorny P, Gabriel S, Willingham AL, Speybroeck N, Vercruysse J. The prevalence of porcine cysticercosis in Eastern and Southern provinces of Zambia. Vet Parasitol. 2002;108:31–9. https://doi.org/10.1016/S0304-4017(02)00165-6 .
doi: 10.1016/S0304-4017(02)00165-6
pubmed: 12191897
Sikasunge CS, Phiri IK, Phiri AM, Siziya S, Dorny P, Willingham AL. Prevalence of Taenia solium porcine cysticercosis in the Eastern, Southern and Western provinces of Zambia. Vet J. 2008;176:240–4. https://doi.org/10.1016/j.tvjl.2007.02.030 .
doi: 10.1016/j.tvjl.2007.02.030
pubmed: 17468023
Chembensofu M, Mwape KE, Van Damme I, Hobbs E, Phiri IK, Masuku M, et al. Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs. Parasit Vectors. 2017. https://doi.org/10.1186/s13071-017-2520-y .
doi: 10.1186/s13071-017-2520-y
pubmed: 29145875
pmcid: 5693468
Mwape KE, Phiri IK, Praet N, Muma JB, Zulu G, van den Bossche P, et al. Taenia solium infections in a rural area of Eastern Zambia—a community based study. PLoS Negl Trop Dis. 2012;6:1–9. https://doi.org/10.1371/journal.pntd.0001594 .
doi: 10.1371/journal.pntd.0001594
Zulu G, Sikasunge CS, Welte TM, Simuunza MC, Stelzle D, Schmidt V, et al. Epidemiology of intestinal helminthiasis with an emphasis on taeniasis in Chipata district of the Eastern province of Zambia. PLoS Negl Trop Dis. 2023;17: e0011561. https://doi.org/10.1371/JOURNAL.PNTD.0011561 .
doi: 10.1371/JOURNAL.PNTD.0011561
pubmed: 37983246
pmcid: 10695371
Mwape KE, Blocher J, Wiefek J, Schmidt K, Dorny P, Praet N, et al. Prevalence of neurocysticercosis in people with epilepsy in the Eastern province of Zambia. PLoS Negl Trop Dis. 2015;9: e0003972. https://doi.org/10.1371/journal.pntd.0003972 .
doi: 10.1371/journal.pntd.0003972
pubmed: 26285031
pmcid: 4540454
Stelzle D, Makasi C, Schmidt V, Trevisan C, van Damme I, Welte TM, et al. Epidemiological, clinical and radiological characteristics of people with neurocysticercosis in Tanzania—a cross-sectional study. PLoS Negl Trop Dis. 2022;16: e0010911. https://doi.org/10.1371/journal.pntd.0010911 .
doi: 10.1371/journal.pntd.0010911
pubmed: 36441777
pmcid: 9704569
Keller L, Stelzle D, Schmidt V, Carabin H, Reinhold AK, Keller C, et al. Community-level prevalence of epilepsy and of neurocysticercosis among people with epilepsy in the Balaka district of Malawi: a cross-sectional study. PLoS Negl Trop Dis. 2022;16: e0010675. https://doi.org/10.1371/journal.pntd.0010675 .
doi: 10.1371/journal.pntd.0010675
pubmed: 36108075
pmcid: 9477368
Stelzle D, Schmidt V, Ngowi BJ, Matuja W, Schmutzhard E, Winkler AS. Lifetime prevalence of epilepsy in urban Tanzania—a door-to-door random cluster survey. ENeurologicalSci. 2021;24: 100352. https://doi.org/10.1016/j.ensci.2021.100352 .
doi: 10.1016/j.ensci.2021.100352
pubmed: 34189286
pmcid: 8220170
Stelzle D, Kaducu J, Schmidt V, Welte TM, Ngowi BJ, Matuja W, et al. Characteristics of people with epilepsy in three Eastern African countries—a pooled analysis. BMC Neurol. 2022. https://doi.org/10.1186/s12883-022-02813-z .
doi: 10.1186/s12883-022-02813-z
pubmed: 36564763
pmcid: 9784276
Van Damme I, Trevisan C, Mwape KE, Schmidt V, Magnussen P, Zulu G, et al. Trial design for a diagnostic accuracy study of a point-of-care test for the detection of Taenia solium taeniosis and (Neuro)cysticercosis in community settings of highly endemic, resource-poor areas in Zambia: challenges and rationale. Diagnostics. 2021. https://doi.org/10.3390/diagnostics11071138 .
doi: 10.3390/diagnostics11071138
pubmed: 34829468
pmcid: 8618153
Mubanga C, Van Damme I, Trevisan C, Schmidt V, Phiri IK, Zulu G, et al. Evaluation of an antibody detecting point of care test for diagnosis of Taenia solium cysticercosis in a Zambian rural community: a prospective diagnostic accuracy study. Diagnostics. 2021. https://doi.org/10.3390/DIAGNOSTICS11112121/S1 .
doi: 10.3390/DIAGNOSTICS11112121/S1
pubmed: 34829468
pmcid: 8618153
Stelzle D, Makasi CE, Schmidt V, Van Damme I, Trevisan C, Ruether C, et al. Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study. Lancet Infect Dis. 2024;24:98–106. https://doi.org/10.1016/S1473-3099(23)00378-X .
doi: 10.1016/S1473-3099(23)00378-X
pubmed: 37660709
Zulu G, Stelzle D, Mwape KE, Van Damme I, Trevisan C, Mubanga C, et al. The performance of a point-of-care test for the diagnosis of neurocysticercosis in a resource-poor community setting in Zambia—a diagnostic accuracy study. 2024. https://doi.org/10.2139/SSRN.4746924 .
Del Brutto OH, Nash TE, White AC, Rajshekhar V, Wilkins PP, Singh G, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202–10. https://doi.org/10.1016/J.JNS.2016.11.045 .
doi: 10.1016/J.JNS.2016.11.045
pubmed: 28017213
Zhao J-L, Lerner A, Shu Z, Gao X-J, Zee C-S. Imaging spectrum of neurocysticercosis. Radiol Infect Dis. 2015;1:94–102. https://doi.org/10.1016/j.jrid.2014.12.001 .
doi: 10.1016/j.jrid.2014.12.001
Escobar A. The pathology of neurocysticercosis. In: Rodriguez-Carbajal J, Taveras J, Taveras J, editors. Cysticercosis Cent. Nerv. Syst. Charles C. Thomas; 1983. p. 27–57.
Coughlin SS, Trock B, Criqui MH, Pickle LW, Browner D, Tefft MC. The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol. 1992;45:1–7. https://doi.org/10.1016/0895-4356(92)90180-U .
doi: 10.1016/0895-4356(92)90180-U
pubmed: 1738006
Lumley T. Survey: analysis of complex survey samples. R Packag Version. 40 2020;9:1–19. https://doi.org/10.18637/jss.v009.i08 .
Gilman RH, Del Brutto OH, García HH, Martínez M. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurology. 2000;55:1062. https://doi.org/10.1212/WNL.55.7.1062 .
doi: 10.1212/WNL.55.7.1062
pubmed: 11061275
Hamamoto Filho PT, Singh G, Winkler AS, Carpio A, Fleury A. Could differences in infection pressure be involved in cysticercosis heterogeneity? Trends Parasitol. 2020;36:826–34. https://doi.org/10.1016/j.pt.2020.07.003 .
doi: 10.1016/j.pt.2020.07.003
pubmed: 32819826
Moyano LM, O’Neal SE, Ayvar V, Gonzalvez G, Gamboa R, Vilchez P, et al. high prevalence of asymptomatic neurocysticercosis in an endemic rural community in Peru. PLoS Negl Trop Dis. 2016. https://doi.org/10.1371/journal.pntd.0005130 .
doi: 10.1371/journal.pntd.0005130
pubmed: 27992429
pmcid: 5167259
Guzman C, Garcia HH. Current diagnostic criteria for neurocysticercosis. Res Rep Trop Med. 2021;12:197–203. https://doi.org/10.2147/rrtm.s285393 .
doi: 10.2147/rrtm.s285393
pubmed: 34408532
pmcid: 8364393
Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis. 1999;29:1203–9. https://doi.org/10.1086/313470 .
doi: 10.1086/313470
pubmed: 10524964
Carabin H, Millogo A, Cissé A, Gabriël S, Sahlu I, Dorny P, et al. Prevalence of and factors associated with human cysticercosis in 60 villages in three provinces of Burkina Faso. PLoS Negl Trop Dis. 2015;9: e0004248. https://doi.org/10.1371/journal.pntd.0004248 .
doi: 10.1371/journal.pntd.0004248
pubmed: 26588468
pmcid: 4654529
Fleury A, Dessein A, Preux P, Dumas M, Tapia G, Larralde C, et al. Symptomatic human neurocysticercosis. J Neurol. 2004;251:830–7. https://doi.org/10.1007/s00415-004-0437-9 .
doi: 10.1007/s00415-004-0437-9
pubmed: 15258785
Cavellani CL, Faleiros ACG, de Lino RS, dos Reis MA, de Teixeira VPA. Cysticercosis in the elderly. Ann Diagn Pathol. 2007;11:330–3. https://doi.org/10.1016/j.anndiagpath.2006.12.008 .
doi: 10.1016/j.anndiagpath.2006.12.008
pubmed: 17870018
Stelzle D, Schmidt V, Keller L, Ngowi BJ, Matuja W, Escheu G, et al. Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries—a pooled analysis. PLoS Negl Trop Dis. 2022;16: e0010870. https://doi.org/10.1371/journal.pntd.0010870 .
doi: 10.1371/journal.pntd.0010870
pubmed: 36342903
pmcid: 9639810
Praet N, Speybroeck N, Rodriguez-Hidalgo R, Benitez-Ortiz W, Berkvens D, Brandt J, et al. Age-related infection and transmission patterns of human cysticercosis. Int J Parasitol. 2010;40:85–90. https://doi.org/10.1016/j.ijpara.2009.07.007 .
doi: 10.1016/j.ijpara.2009.07.007
pubmed: 19683531
Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, et al. Calcific neurocysticercosis and epileptogenesis. Neurology. 2004;62:1934–8. https://doi.org/10.1212/01.WNL.0000129481.12067.06 .
doi: 10.1212/01.WNL.0000129481.12067.06
pubmed: 15184592
Carpio A, Romo ML. The relationship between neurocysticercosis and epilepsy: an endless debate. Arq Neuropsiquiatr. 2014;72:383–90. https://doi.org/10.1590/0004-282X20140024 .
doi: 10.1590/0004-282X20140024
pubmed: 24863516
Stelzle D, Makasi C, Schmidt V, Trevisan C, Van Damme I, Ruether C, et al. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study. Infection. 2023;51:1127–39. https://doi.org/10.1007/s15010-023-02021-y .
doi: 10.1007/s15010-023-02021-y
pubmed: 36961623
pmcid: 10037392
Adamczyk B, Węgrzyn K, Wilczyński T, Maciarz J, Morawiec N, Adamczyk-Sowa M. The most common lesions detected by neuroimaging as causes of epilepsy. Med. 2021;57:294. https://doi.org/10.3390/medicina57030294 .
doi: 10.3390/medicina57030294
Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology. 2003;22:139–45. https://doi.org/10.1159/000068748 .
doi: 10.1159/000068748
pubmed: 12629280
Carpio A, Romo ML. Multifactorial basis of epilepsy in patients with neurocysticercosis. Epilepsia. 2015;56:973–4. https://doi.org/10.1111/epi.12978 .
doi: 10.1111/epi.12978
pubmed: 26040532
Fogang YF, Savadogo AA, Camara M, Toffa DH, Basse A, Sow AD, et al. Managing neurocysticercosis: challenges and solutions. Int J Gen Med. 2015;8:333–44. https://doi.org/10.2147/IJGM.S73249 .
doi: 10.2147/IJGM.S73249
pubmed: 26527895
pmcid: 4621219
Pradhan S, Das A, Anand S, Deshmukh AR. Clinical characteristics of migraine in patients with calcified neurocysticercosis. Trans R Soc Trop Med Hyg. 2019;113:418–23. https://doi.org/10.1093/trstmh/trz018 .
doi: 10.1093/trstmh/trz018
pubmed: 30953442
Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–76. https://doi.org/10.1016/S1474-4422(18)30322-3 .
doi: 10.1016/S1474-4422(18)30322-3
Winkler AS, Stelzhammer B, Kerschbaumsteiner K, Meindl M, Dent W, Kaaya J, et al. The prevalence of headache with emphasis on tension-type headache in rural Tanzania: a community-based study. Cephalalgia. 2009;29:1317–25. https://doi.org/10.1111/j.1468-2982.2009.01885.x .
doi: 10.1111/j.1468-2982.2009.01885.x
pubmed: 19438921
Winkler AS, Dent W, Stelzhammer B, Kerschbaumsteiner K, Meindl M, Kaaya J, et al. Prevalence of migraine headache in a rural area of northern Tanzania: a community-based door-to-door survey. Cephalalgia. 2010;30:582–92. https://doi.org/10.1111/j.1468-2982.2009.01994.x .
doi: 10.1111/j.1468-2982.2009.01994.x
pubmed: 19735479
Del Brutto OH, Robles AM, Mera RM, Costa AF, Darsan E, Milla L, et al. Calcified neurocysticercosis and headache in an endemic village: a case-control study nested to a population-based cohort. Am J Trop Med Hyg. 2018;99:729–34. https://doi.org/10.4269/ajtmh.18-0310 .
doi: 10.4269/ajtmh.18-0310
pubmed: 29943721
pmcid: 6169166